Annals of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지)

The Korean Association of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회)
권호 표지

Clinical Outcome of 457 Hepatic Resection Cases for the Treatment of Hepatocellular Carcinoma

간세포암 절제술 457례의 임상결과

  • Yim, Jin-Ho (Department of Surgery, Korea Cancer Center Hospital) ;
  • Kim, Sang-Bum (Department of Surgery, Korea Cancer Center Hospital) ;
  • Cho, Eung-Ho (Department of Surgery, Korea Cancer Center Hospital) ;
  • Choi, Dong-Wook (Department of Surgery, Samsung Medical Center, Sungkyunkwan University)
  • Published : 2009.09.30

⟨ Previous Next ⟩

Abstract

Background & Purpose : This purpose of this study was to determine the prognostic factors for hepatocellular carcinoma (HCC) in patients who received curative hepatectomies at our institution Patient and Method : A retrospective analysis was performed on 457 patients who had undergone hepatectomies between Mar 1987 and Feb 2008 for HCC at the Korea Cancer Center Hospital, Seoul, Korea. The number of males enrolled in the study was 366 and the number of females enrolled was 91. The mean age of the patients was 52.8 years old Hepatitis B virus-related disease was the most frequent etiology (335/457 patients). Two hundred nine (209) patients had liver cirrhosis, and 93.9% of patients were classified in Child-Pugh Class A. Result : The complication rate was 30.6% (140/457) and the operative mortality was 1.5% (7/457). Reoperation was performed in 7 complicated patients. Five- and 10-year overall survival rates of the patients were 57.7% and 41 .8% respectively. Poor prognostic factors of overall survival were Child B class, Edmonson-Steiner histologic grade 3 or 4, tumor vascular invasion, and postoperative complications. Five-and 10-year disease-free survival rates were 42.7% and 32.5%, respectively. Poor prognostic factors for disease free survival included the following an Edmonson-Steiner histologic grade of 3 or 4, tumor vascular invasion, and postoperative complications. Conclusion : Postoperative complication is independently a poor prognostic factor for overall and disease free survival in our study. We suggest that special care is needed while performing hepatic resections for the treatment of HCC in order to reduce postoperative complications.

Keywords

References

  1. Annual report of Korean central cancer registry program. Ministry of Health and Welfare, Republic of Korea. 2002.
  2. Blum HE. Hepatocelllar carcinoma: Therapy and Prevention. World J GastroenteroI 2005;7391-7400.
  3. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989;124:1025-1028. https://doi.org/10.1001/archsurg.1989.01410090031006
  4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236. https://doi.org/10.1002/hep.20933
  5. Sasaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil. cisplatin, and gelatin sponge, Cancer 1987;9:1194-1203.
  6. Wellwood JM, Cady B, Oberfield RA. Treatment of primary liver cancer : response to regional chemotherapy. Clin Oncol 1979;5:25-31. https://doi.org/10.1016/S0936-6555(05)80691-0
  7. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. lnt J Radiat Oncol Biol Phys 1995:31:1237-1248. https://doi.org/10.1016/0360-3016(94)00418-K
  8. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70. https://doi.org/10.1097/00000658-200107000-00010
  9. Eugenio Caturelli, Francesca Bartolucci, Elisabetta Biasini, et al. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 200;97:397-405. https://doi.org/10.1111/j.1572-0241.2002.05477.x
  10. Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996;131:71-76. https://doi.org/10.1001/archsurg.1996.01430130073014
  11. Ronnie Tung-Ping Poon, Sheung-Tat Fan, M,S., Irene Oi-Lin Ng, Chung-Mau Lo, Chi-Leung Liu, John Wong. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-507 https://doi.org/10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O
  12. Lee JG, Kang CM,Park JS et al. The actual Five-year survival Rate of hepatocellular carcinoma patient after curative resection. Yonsei Med J 2006;47:105-112. https://doi.org/10.3349/ymj.2006.47.1.105
  13. John AR, Khan S, Mirza OF, Mayer AD, Buckels JA, Bramhall SR. Multivariate and univariate analysis of prognosticfactors following resection in HCC: the Birmingham experience. Dig Surg 2006;23:103-109. https://doi.org/10.1159/000093779
  14. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in japan. Liver Transpl 2004;10:S46-52 https://doi.org/10.1002/lt.20044
  15. Benzoni E, Roberta Molaro R, Carla Cedolini C et al. Liver resection for HCC: analysis of causes and risk factors linked to postoperative complications. Hepatogastroenterology 2007;54:186-189.
  16. Poon RT, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrance after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24. https://doi.org/10.1097/00000658-200007000-00003
  17. Hanazaki K, Kajikawa S, Shimozawa N,et al. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 2005;52:524-529.